We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Demonstrates Hematology and Total Laboratory Automation Solutions

By LabMedica International staff writers
Posted on 29 Jul 2025

Mindray (Shenzhen, China) is returning to ADLM after five years to unveil cutting-edge lab innovations and clinical insights. More...

At ADLM 2025, Mindray is highlighting the MT 8000 Intelligent TLA Solution designed for streamlined, automated laboratory operations. The MT 8000 Intelligent TLA Solution promises to revolutionize lab operations with unmatched flexibility and automation across five critical disciplines. Mindray is also highlighting the M6000 Laboratory Automation System that can empower ultra-high volume laboratories with high processing speed, less hands-on time, great cost efficiency, and standardized analytical quality.

Visitors to Mindray’s booth at ADLM 2025 can also experience its ALL IN ONE Hematology Solution that brings greater efficiency to hematology testing with simplified workflows and ease of operation. It enables end-to-end automation throughout the process, from tube sorting through to analysis of CBC, ESR, CRP, and HbA1c with a single EDTA tube, smear preparation, and slide reading. The solution is ideal for core or centralized laboratories with mid-to-high sample volumes and a high demand for turnaround times.

The focus is also on the CAL 9000 New Generation Cellular Analysis Line that showcases Mindray's expertise and innovation for large-volume hematology laboratories. Mindray is also showcasing the M1000 chemistry and immunoassay integrated solution for large-scale laboratories alongside the M980 chemistry and immunoassay integrated solution for mid-scale laboratories.

Mindray is presenting the FA-N60 next-generation scalable blood culture system that features real-time blood volume monitoring, an intelligent satellite information transmission system, and newly designed culture bottles. It enables rapid diagnosis of bloodstream infections with an optimized workflow. In addition, visitors to the company’s booth can experience the CX-6000 Series next-generation mid-end automated coagulation analyzer that has been developed based on the CX-9000 Series platform.

Also being highlighted at ADLM 2025 is the Mindray EU 8600 (and EU 8600 GT) fully automated urinalysis system designed for high-throughput laboratories, featuring multi-depth-of-field fusion, vibration-proof system, 2K full-color clear imaging, and high analysis volume for sediment particles. In addition to presenting innovative breakthroughs,

Additionally, Mindray is also holding expert-led workshops shaping the future of laboratory diagnostics. This includes a workshop on hs-cTnI (high-sensitivity cardiac troponin I) and expert-led discussions on advancing myocardial injury management. Mindray’s focus on high-sensitivity cardiac troponin I clinical insights highlights important advances and ongoing challenges in myocardial injury management—an essential conversation for improving patient outcomes.

Related Links:
Mindray


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Chemistry System
P780
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.